Home|Journals|Articles by Year|Audio Abstracts
 

Short Communication

crjmed. 2024; 3(1): 27-30


Validity and Reliability of the Negative Acts Questionnaire-Revised among Nigerian Medical Students

Olaolu A. Olasubulu, Emmanuel A. Essien, Maxwell B. Ugobo, Emmanuel O. Olose, Joseph Okegbe, Bassey E. Edet.




Abstract

BACKGROUND: The Negative Acts Questionnaire-Revised (NAQ-R) is used globally to assess workplace bullying. However, its validity and reliability have not been assessed among Nigerians.
Aim: This study assessed the validity and reliability of the Negative Acts Questionnaire-Revised among medical students at the University of Calabar, Nigeria.
METHOD: A cross-sectional study was conducted at the University of Calabar. All 123 students in the fifth-year class were approached for participation. The Negative Acts Questionnaire-Revised (NAQ-R) and General Health Questionnaire (GHQ-12) were administered concurrently. Data were analysed using IBM SPSS version 23.
RESULT: We recruited 119 participants (response rate, 96.74%). Most were males [68, 57.1%] and unmarried [114, 95.8%]. The mean age of the sample was 25.2 (SD=3.2). Probable mental disorder was identified in 52 (43.7%) students, while 64 (53.8%) and 25 (21.0%) were classified as occasionally bullied or bullied, respectively. The correlation between the NAQ-R and the GHQ-12 was 0.47 (p

Key words: Bullying, Medical Students, Reproducibility of Results, Nigeria






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.